CYTOTOXIC T-LYMPHOCYTE PRECURSOR FREQUENCIES IN BALB C MICE AFTER ACUTE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION OR IMMUNIZATION WITH A FORMALIN-INACTIVATED RSV VACCINE/
Ra. Tripp et Lj. Anderson, CYTOTOXIC T-LYMPHOCYTE PRECURSOR FREQUENCIES IN BALB C MICE AFTER ACUTE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION OR IMMUNIZATION WITH A FORMALIN-INACTIVATED RSV VACCINE/, Journal of virology (Print), 72(11), 1998, pp. 8971-8975
A better understanding of the immune response to live and formalin-ina
ctivated respiratory syncytial virus (RSV) is important for developing
nonlive vaccines. In this study, major histocompatibility complex (MH
C) class I- and II-restricted, RSV-specific cytotoxic T-lymphocyte pre
cursor (CTLp) frequencies were determined in bronchoalveolar lavage (B
AL) samples and spleen lymphocytes of BALB/c mice intranasally infecte
d with live RSV or intramuscularly inoculated with formalin-inactivate
d RSV (FI-RSV), After RSV infection, both class I- and class Ii-restri
cted CTLps were detected by day 4 or 5 postinfection (p.i.), Peak CTLp
frequencies were detected by day 7 p.i, The class II-restricted CTLp
frequencies in the BAL following RSV infection were less than class I-
restricted CTLp frequencies through day 14 p.i., during which class I-
restricted CTLp frequencies remained elevated, but then declined by 48
days p.i. The frequencies of class II-restricted CTLps in the BAL wer
e 2- to 10-fold less than those of class I-restricted CTLps. For splee
n cells, frequencies of both MHC class I- and II-restricted CTLps to l
ive RSV were similar. In contrast, class II-restricted CTLps predomina
ted in FI-RSV-vaccinated mice. RSV challenge of vaccinated mice result
ed in an increase in the frequency of class I-restricted CTLps at day
3 p.i. but did not enhance class II-restricted CTLp frequencies. These
studies demonstrate differences in the CTLp response to live RSV infe
ction compared with FI-RSV immunization and help define possible mecha
nisms of enhanced disease after FI-RSV immunization. In addition, thes
e studies provide a quantitative means to address potential vaccine ca
ndidates by examining both MHC class I- and II-restricted CTLp frequen
cies.